NK

Narender Kumar

Active Director Director DIN 02227276
DIN 02227276 First appointment Aug 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2008
Shareholding value •••• Premium profile

About Narender Kumar

Data last updated:

Narender Kumar is a Director at G Nine Bioceuticals Private Limited (since 2008). The company operates in Pharma. G Nine Bioceuticals Private Limited reported revenue of ₹19.42 Cr (FY 2025).

DIN 02227276
Primary Designation Director
Industry Pharma
First Appointment 19 Aug 2008
Oldest Company Age 18 yrs
Largest company G Nine Bioceuticals Private Limited · ₹19.42 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
G Nine Bioceuticals Private Limited U74900HR2008PTC038275
Director19 Aug 20082008₹19.42 Cr (FY 2025)Active

Board colleagues of Narender Kumar

NameDINCompanyDesignation
Robin08776031G Nine Bioceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
G Nine Bioceuticals Private Limited
Premium access

Shareholding and investment profile for Narender Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narender Kumar

Narender Kumar currently holds 1 directorship: G Nine Bioceuticals Private Limited (Director, since 19 Aug 2008, revenue ₹19.42 Cr (FY 2025)).

Narender Kumar was first appointed on 19 Aug 2008 as Director at G Nine Bioceuticals Private Limited.

The current boards of Narender Kumar's companies include Robin (G Nine Bioceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available